Insider Buying Fuels Optimism for Anixa Biosciences Amid FDA & EMA Pipeline Momentum
Insider buying at Anixa Biosciences shows steady confidence as the company secures Mexican patents, advances breast‑cancer vaccine trials, and plans FDA approval, hinting at long‑term growth.
3 minutes to read